Aclarion, Inc. (NASDAQ:ACONW) Short Interest Update

Aclarion, Inc. (NASDAQ:ACONW) was the target of a significant increase in short interest during the month of June. As of June 15th, there was short interest totaling 2,445 shares, an increase of 304.8% from the May 31st total of 604 shares. Based on an average trading volume of 7,826 shares, the short-interest ratio is currently 0.3 days.

Aclarion Stock Performance

NASDAQ ACONW opened at $0.03 on Friday. The company’s fifty day moving average is $0.03 and its two-hundred day moving average is $0.04. Aclarion has a 52-week low of $0.02 and a 52-week high of $0.23.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.